Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Questionnaire survey on malnutrition when encapsulating Enzarutamide, in collaborat on with a pharmacy dispensing pharmacy at Hakodate Municipal Hospital -Part2-

Trial Profile

Questionnaire survey on malnutrition when encapsulating Enzarutamide, in collaborat on with a pharmacy dispensing pharmacy at Hakodate Municipal Hospital -Part2-

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 27 Dec 2018

At a glance

  • Drugs Enzalutamide (Primary)
  • Indications Prostate cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 23 Dec 2018 Planned End Date changed from 31 Dec 2018 to 30 Sep 2019.
    • 14 Jun 2018 Status changed from not yet recruiting to recruiting.
    • 05 Jan 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top